⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
globenewswire.com
TLX
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
prnewswire.com
TLX
MYGN
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
globenewswire.com
TLX
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
globenewswire.com
TLX
Investor Education Webinar
globenewswire.com
TLX
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging
globenewswire.com
TLX
Telix to Participate in Oppenheimer and TD Cowen Conferences
globenewswire.com
TLX
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
globenewswire.com
TLX
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
globenewswire.com
TLX
Co-PSMA: Cu-64 SAR-bisPSMA more than doubled prostate cancer lesion and patient detection vs. Ga-68 PSMA-11 in head-to-head trial
prnewswire.com
TLX